Non-engineered T cells with specific anticancer effects in KRAS-mutated colorectal cancer

被引：0
|
作者：
Lim, Sunki [1 ]
Gho, Yujeong [1 ]
Kim, Seoyoung [1 ]
Kim, Min Ki [1 ]
Park, Jong Seob [1 ]
Lee, Wang Jun [1 ]
Lee, Young-Kwan [1 ]
Moon, Hyoun Jong [1 ]
机构：
[1] Excelsisbio Inc, Goyang, South Korea
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3200
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3200
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Everolimus inhibits invasion and angiogenesis in a KRAS-mutated mesenchymal-differentiated colorectal cancer xenografts
    Tijeras-Raballand, Annemilai
    Dos Santos, Celia
    Serova, Maria
    Riveiro, Maria Eugenia
    de Gramont, Armand
    Faivre, Sandrine
    Raymond, Eric
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [22] KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
    Spindler, K. G.
    Appelt, A. L.
    Pallisgaard, N.
    Andersen, R. F.
    Jakobsen, A.
    BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 3067 - 3072
  • [23] Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
    Masanobu Tsubaki
    Tomoya Takeda
    Takuya Matsuda
    Kana Kishimoto
    Honoka Takefuji
    Yuzuki Taniwaki
    Misa Ueda
    Tadafumi Hoshida
    Kazufumi Tanabe
    Shozo Nishida
    Cancer Cell International, 23
  • [24] KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
    K G Spindler
    A L Appelt
    N Pallisgaard
    R F Andersen
    A Jakobsen
    British Journal of Cancer, 2013, 109 : 3067 - 3072
  • [25] CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab
    Arriga, Roberto
    Caratelli, Sara
    Lanzilli, Giulia
    Ottaviani, Alessio
    Cenciarelli, Carlo
    Sconocchia, Tommaso
    Spagnoli, Giulio C.
    Iezzi, Giandomenica
    Roselli, Mario
    Lauro, Davide
    Coppola, Andrea
    Dotti, Gianpietro
    Ferrone, Soldano
    Sconocchia, Giuseppe
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2531 - 2538
  • [26] Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
    Sousa, Catarina C.
    Pinto, Josue
    Martins, Natalia
    Teixeira, Sofia
    Magalhaes, Adriana
    Fernandes, Gabriela
    Hespanhol, Venceslau
    Queiroga, Henrique
    Bastos, Helder Novais
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [27] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 1210 - 1210
  • [28] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 783 - 783
  • [29] Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer
    van Brummelen, Emilie M. J.
    Huijberts, Sanne
    van Herpen, Carla
    Desar, Ingrid
    Opdam, Frans
    van Geel, Robin
    Marchetti, Serena
    Steeghs, Neeltje
    Monkhorst, Kim
    Thijssen, Bas
    Rosing, Hilde
    Huitema, Alwin
    Beijnen, Jos
    Bernards, Rene
    Schellens, Jan
    ONCOLOGIST, 2021, 26 (04): : 290 - +
  • [30] Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells
    Hara, Yuta
    Minami, Yushi
    Yoshimoto, Soshi
    Hayashi, Natsumi
    Yamasaki, Akitaka
    Ueda, Shiho
    Masuko, Kazue
    Masuko, Takashi
    CANCER MEDICINE, 2020, 9 (01): : 302 - 312
12345